Cargando…
Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy
Type 2 diabetes mellitus (T2DM) has become one of the leading causes of morbidity and mortality in developed countries. Low efficacy, weight gain, and hypoglycemia are the main pitfalls of previous treatments for T2DM. New therapies have been designed with the aim of improving the results in efficac...
Autores principales: | Gomez-Peralta, Fernando, Abreu, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388990/ https://www.ncbi.nlm.nih.gov/pubmed/30863012 http://dx.doi.org/10.2147/DDDT.S165372 |
Ejemplares similares
-
Semaglutide for type 2 diabetes
Publicado: (2020) -
Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists
por: Kane, Michael P, et al.
Publicado: (2020) -
Population Pharmacokinetics of Semaglutide for Type 2 Diabetes
por: Overgaard, Rune V., et al.
Publicado: (2019) -
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
por: Romigi, Andrea, et al.
Publicado: (2018) -
Clinical Research on Type 2 Diabetes: A Promising and Multifaceted Landscape
por: Gómez-Peralta, Fernando, et al.
Publicado: (2022)